MGBRX
Price
$16.15
Change
+$0.04 (+0.25%)
Updated
Jan 17 closing price
Net Assets
1.23B
RIRBX
Price
$70.01
Change
+$0.35 (+0.50%)
Updated
Jan 17 closing price
Net Assets
106.93B
Ad is loading...

MGBRX vs RIRBX

Header iconMGBRX vs RIRBX Comparison
Open Charts MGBRX vs RIRBXBanner chart's image
MFS Global Total Return R2
Price$16.15
Change+$0.04 (+0.25%)
VolumeN/A
Net Assets1.23B
American Funds Capital Income Bldr R2
Price$70.01
Change+$0.35 (+0.50%)
VolumeN/A
Net Assets106.93B
MGBRX vs RIRBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MGBRX vs. RIRBX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGBRX is a Hold and RIRBX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIRBX has more cash in the bank: 107B vs. MGBRX (1.23B). RIRBX pays higher dividends than MGBRX: RIRBX (2.55) vs MGBRX (1.72). MGBRX was incepted earlier than RIRBX: MGBRX (21 years) vs RIRBX (23 years). RIRBX is a more actively managed with annual turnover of: 106.00 vs. MGBRX (69.00). MGBRX has a lower initial minimum investment than RIRBX: MGBRX (0) vs RIRBX (250). RIRBX annual gain was more profitable for investors over the last year : 9.89 vs. MGBRX (0.35). RIRBX return over 5 years is better than : 19.51 vs. MGBRX (-7.17).
MGBRXRIRBXMGBRX / RIRBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years23 years-
Gain YTD0.7491.40553%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.23B107B1%
Annual Yield % from dividends1.722.5567%
Returns for 1 year0.359.894%
Returns for 3 years-8.015.65-142%
Returns for 5 years-7.1719.51-37%
Returns for 10 years10.2030.0934%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTCT43.840.76
+1.76%
PTC Therapeutics
CBAN15.840.22
+1.41%
Colony Bankcorp Inc
ABCL2.970.03
+1.02%
AbCellera Biologics
PAVM0.650.01
+0.81%
PAVmed
EXPE187.28-1.39
-0.74%
Expedia Group